Skip to main content
Journal cover image

Arterial thromboembolic events and patients with metastatic carcinoma treated with chemotherapy and bevacizumab (Journal of the National Cancer Institute (2007) 99 (1232-1239))

Publication ,  Journal Article
Scappaticci, FA; Skillings, JR; Holden, SN; Gerber, HP; Miller, K; Kabbinavar, F; Bergsland, E; Ngai, J; Holmgren, E; Wang, J; Hurwitz, H
Published in: Journal of the National Cancer Institute
May 1, 2008

Duke Scholars

Published In

Journal of the National Cancer Institute

DOI

EISSN

1460-2105

ISSN

0027-8874

Publication Date

May 1, 2008

Volume

100

Issue

9

Start / End Page

685

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Scappaticci, F. A., Skillings, J. R., Holden, S. N., Gerber, H. P., Miller, K., Kabbinavar, F., … Hurwitz, H. (2008). Arterial thromboembolic events and patients with metastatic carcinoma treated with chemotherapy and bevacizumab (Journal of the National Cancer Institute (2007) 99 (1232-1239)). Journal of the National Cancer Institute, 100(9), 685. https://doi.org/10.1093/jnci/djn126
Scappaticci, F. A., J. R. Skillings, S. N. Holden, H. P. Gerber, K. Miller, F. Kabbinavar, E. Bergsland, et al. “Arterial thromboembolic events and patients with metastatic carcinoma treated with chemotherapy and bevacizumab (Journal of the National Cancer Institute (2007) 99 (1232-1239)).” Journal of the National Cancer Institute 100, no. 9 (May 1, 2008): 685. https://doi.org/10.1093/jnci/djn126.
Scappaticci FA, Skillings JR, Holden SN, Gerber HP, Miller K, Kabbinavar F, et al. Arterial thromboembolic events and patients with metastatic carcinoma treated with chemotherapy and bevacizumab (Journal of the National Cancer Institute (2007) 99 (1232-1239)). Journal of the National Cancer Institute. 2008 May 1;100(9):685.
Scappaticci, F. A., et al. “Arterial thromboembolic events and patients with metastatic carcinoma treated with chemotherapy and bevacizumab (Journal of the National Cancer Institute (2007) 99 (1232-1239)).” Journal of the National Cancer Institute, vol. 100, no. 9, May 2008, p. 685. Scopus, doi:10.1093/jnci/djn126.
Scappaticci FA, Skillings JR, Holden SN, Gerber HP, Miller K, Kabbinavar F, Bergsland E, Ngai J, Holmgren E, Wang J, Hurwitz H. Arterial thromboembolic events and patients with metastatic carcinoma treated with chemotherapy and bevacizumab (Journal of the National Cancer Institute (2007) 99 (1232-1239)). Journal of the National Cancer Institute. 2008 May 1;100(9):685.
Journal cover image

Published In

Journal of the National Cancer Institute

DOI

EISSN

1460-2105

ISSN

0027-8874

Publication Date

May 1, 2008

Volume

100

Issue

9

Start / End Page

685

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis